Skip to content

Effects of Musical Intervention by a Therapist (IMT) on Falling Asleep and Behavioral Regulation in a Secure Care Unit (SCU)

Effects of Musical Intervention by a Therapist (IMT) on Falling Asleep and Behavioral Regulation in a Secure Care Unit (SCU) Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07465783
Acronym
DOUCE NUIT IMT
Enrollment
48
Registered
2026-03-12
Start date
2026-02-02
Completion date
2027-09-01
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease or Associated Disorder

Keywords

Alzheimer's disease, Behavior disorder, Music intervention

Brief summary

This is a prospective, multicenter study designed to evaluate the benefits of an evening music-based intervention on sundowning syndrome in patients with Alzheimer's disease or related disorders in a Protect lLife Unit setting.

Detailed description

This study will employ a randomized, cluster-organized, crossover design to compare the effects of a music-based intervention (TEST) with an audiobook listening intervention (CONTROL). Both interventions will be delivered by a therapist in the participants' living environment over ten evening sessions per intervention period. Each participant will serve as their own control and will be exposed to both intervention conditions. The sequence of intervention periods ("TEST followed by CONTROL" or "CONTROL followed by TEST") will be randomized at the cluster level within participating protected care units (UVP). Behavioral and actigraphic outcomes will be collected and analyzed at baseline, during, and after each intervention period.

Interventions

OTHERTest musicale intervention

listenning music

OTHERControle: audio book

listenning audio books

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER
Lyon Neuroscience Research Center (CRNL)
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Signature of consent by the patient's legal guardian obtained after providing information * Patients aged 60 and over who meet the diagnostic criteria for Alzheimer's disease and related disorders, including mainly: Lewy body disease, frontotemporal lobar degeneration, progressive supranuclear palsy, corticobasal degeneration, vascular encephalopathy, alcoholic dementia, primary progressive aphasia syndrome, posterior cortical atrophy syndrome (France Alzheimer, 2024). * Patient living in a secure care unit * If taking psychotropic drugs, they must have been stable for 3 months * If taking level 2 or 3 painkillers, they must have been stable for 1 month

Exclusion criteria

* Refusal to participate * Participation in a study on a drug/medical device/treatment technique that may affect sleep or behavior. * Highly sedated patients, * Patients with acute medical instability, * Patients with productive delusions, * Patients who have been in the unit for less than 1 month

Design outcomes

Primary

MeasureTime frameDescription
MusicBaseline (Days 1-10); TEST intervention (Days 11-20); post-intervention follow-up (Days 21-40); CONTROL intervention (Days 41-50); post-control follow-up (Days 51-60). Outcomes assessed throughout all study periods.Changing in sleep duration, following an evening music-based intervention in older adults with Alzheimer's disease or related disorders living in a protected care unit (UVP), assessed by actigraphy

Secondary

MeasureTime frameDescription
sleep parameter (1)hroughout all study periods (Days 1-60, including baseline, TEST intervention, post-TEST follow-up, CONTROL intervention, post-CONTROL follow-up)Change in sleep onset latency , assessed by actigraphy.
Daytime disruptive behaviorsThroughout all study periods (Days 1-60).Change in disruptive behaviors assessed using the Cohen-Mansfield Agitation Inventory (CMAI), a categorical agitation scale, (score 0 to 29, Low score : low or infrequent agitation ; High score : frequent or intense agitation
FallsThroughout all study periods (Days 1-60)Change in the number of falls recorded during each study period.
sleep parameter (2)Throughout all study periods (Days 1-60, including baseline, TEST intervention, post-TEST follow-up, CONTROL intervention, post-CONTROL follow-up)number of nocturnal awakenings, assessed by actigraphy.

Countries

France

Contacts

CONTACTIsabelle ROUCH, MD
isabelle.rouch@chu-st-etienne.fr(0)477127399
CONTACTCéline BORG, PhD
celine.borg@chu-st-etienne.fr(0)477127805
PRINCIPAL_INVESTIGATORIsabelle ROUCH, MD

CHU de Saint-Etienne

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026